GeneDx Holdings (WGS) Fundamental Analysis: Revenue, Earnings & Valuation

0.69 / 10

Underperform

Fundamental analysis rates WGS as Underperform with a 0.7/10 score. Key metrics such as ROE (‑7.6%) and quick ratio (2.34) are poor, while Asset‑MV is negative. The company shows defensive characteristics but lacks growth drivers.

Analysis Checks(8/10)

Net assets per share (growth rate compared to beginning of year %)

Value20.38

Score2/3

Weight18.16%

1M Return-0.89%

Annualized return on equity (%)

Value-7.60

Score3/3

Weight-15.88%

1M Return0.85%

Quick ratio

Value2.34

Score1/3

Weight31.05%

1M Return-2.25%

Fixed assets turnover ratio

Value6.53

Score2/3

Weight23.24%

1M Return-1.28%

Long-term debt to working capital ratio (%)

Value0.67

Score3/3

Weight-59.49%

1M Return3.06%

Interest coverage ratio (EBIT / Interest expense) (%)

Value35.11

Score2/3

Weight51.66%

1M Return-3.03%

Asset-MV

Value-0.49

Score1/3

Weight72.57%

1M Return-5.03%

ROE (%)

Value-7.60

Score3/3

Weight-15.88%

1M Return0.85%

Current assets / Total assets (%)

Value51.23

Score2/3

Weight28.01%

1M Return-1.58%

Cash-MV

Value0.02

Score3/3

Weight-33.44%

1M Return1.72%

Is WGS undervalued or overvalued?

WGS scores 0.69/10 on fundamentals and holds a Premium valuation at present. Backed by its -7.60% ROE, -4.92% net margin, -79.54 P/E ratio, 5.43 P/B ratio, and 62.37% earnings growth, these metrics solidify its Underperform investment rating.